《盈警響號》昭衍新藥(06127.HK)預計半年淨利跌70%-80%

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

《盈警響號》昭衍新藥(06127.HK)預計半年淨利跌70%-80%

阿思達克 07-17 00:37

昭衍新藥(06127.HK)發盈警，按中國會計準則，預計6月止六個月淨利潤介乎7,277萬至1.1億人民幣，按年下降70.4%-80.4%。主要是公司持有的生物資產因市價下跌，公允價值變動損失對業績產生消極影響。

昭衍新藥(06127.HK)

Relevant Stocks

昭衍新藥(06127.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

《盈警響號》昭衍新藥(06127.HK)預計半年淨利跌70%-80%

Services

About Us

Agreement Statement